Understanding brain changes related to chronic pain in cerebral palsy

Anatomical and Functional Imaging Correlates of Chronic Pain in Cerebral Palsy

Observational Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · NCT05197946

This study looks at how brain changes in people with cerebral palsy are linked to chronic pain and sensory issues to help improve pain management for these patients.

Quick facts

Study typeObservational
Enrollment300 (estimated)
Ages8 Years and up
SexAll
SponsorHugo W. Moser Research Institute at Kennedy Krieger, Inc. Academic / other
Locations4 sites (Baltimore, Maryland and 3 other locations)
Trial IDNCT05197946 on ClinicalTrials.gov

What this trial studies

This observational study aims to identify and characterize the disruption patterns in sensorimotor networks associated with chronic pain and sensory deficits in individuals with cerebral palsy (CP). By utilizing existing medical records, subjective reports, and MRI data, the researchers will non-invasively explore the correlation between brain injuries and pain mechanisms. The study seeks to improve the understanding of how anatomical brain changes relate to pain and sensory loss, potentially leading to better precision in diagnosing and managing pain subtypes in CP patients.

Who should consider this trial

Good fit: Ideal candidates include individuals aged 8 and older with a diagnosis of cerebral palsy.

Not a fit: Patients with clinically significant neurologic or developmental diagnoses may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and management strategies for chronic pain in individuals with cerebral palsy.

How similar studies have performed: While the approach of using MRI to study chronic pain in CP is innovative, similar studies have shown promise in understanding brain mechanisms related to pain in other conditions.

Eligibility criteria

Show full inclusion / exclusion criteria
Participants with CP (Survey-only):

Inclusion Criteria:

* Individual 8+ years of age
* Diagnosis of cerebral palsy

Exclusion Criteria:

-None

Neurotypical participants: (Survey-only):

Inclusion Criteria:

* Individual 8+ years of age
* Adult subject able to indicate understanding and affirmative consent OR Adult/child subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents

Exclusion Criteria:

-Clinically-significant neurologic or developmental diagnosis

Participants with CP (Survey and MRI):

Inclusion Criteria:

* Individual 8+ years of age
* Adult subject able to indicate understanding and affirmative consent OR Adult subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents
* Diagnosis of cerebral palsy
* Clinical imaging demonstrating isolated periventricular white matter injury
* Clinical judgment that all neurologic symptoms are attributable to non-progressive periventricular white matter injury
* Able to lie still in scanner for 1.5 hours in at most 2 sessions and be able to have MRI

Exclusion Criteria:

-None

Neurotypical participants (Survey and MRI):

Inclusion Criteria:

* Individual 8+ years of age
* Adult subject able to indicate understanding and affirmative consent
* Able to lie still in scanner for 1.5 hours and be able to have MRI

Exclusion Criteria:

-Clinically-significant neurologic or developmental diagnosis

Where this trial is running

Baltimore, Maryland and 3 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Cerebral PalsyChronic Pain
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.